Table 1.
Among 300 Sampled | Estimated number (percentage among low EF in Cohort A) | |
---|---|---|
Total Confirmed EF ≤0.35 | 137 | 692 (100) |
Total Contraindications | 89 | 499 (72) |
Newly diagnosed heart failure* | 14 | 78 (11) |
Died† | 14 | 78 (11) |
Recent MI‡, PCI/CABG§ | 12 | 78 (11) |
DNR | 11 | 58 (8) |
Patient Refusal/ Reluctance | 10 | 62 (9) |
Non-compliance | 8 | 27 (4) |
Advanced cancer | 6 | 45 (6) |
Dementia | 5 | 31 (4) |
NYHA-I with non-ischemic disease | 5 | 19 (3) |
Primary Care Refusal | 1 | 8 (1) |
Awaiting kidney transplant | 1 | 8 (1) |
ICD offered but no follow-up | 1 | 3 (<1) |
Pregnancy | 1 | 3 (<1) |
Low EF study within 3 months of chart review.
Died within 3 months of low EF or chart review.
Within 40 days of encounter.
Within 3 months of encounter.
ICD indicates implantable cardioverter-defibrillator; EF, left ventricular ejection fraction; MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; DNR, do not resuscitate; NYHA, New York Heart Association functional class.